Exome Asset Management »

Crescent Biopharma shares owned by Exome Asset Management

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 153k 18.37

More positions owned by Exome Asset Management

Praxis Precision Medicines I Com New (PRAX)
Cogent Biosciences (COGT)
Enliven Therapeutics (ELVN)
Ionis Pharmaceuticals (IONS)
Spdr Series Trust State Street Spd Put Option (XBI)
Guardant Health (GH)
Cytokinetics Com New (CYTK)
Eli Lilly & Co. (LLY)
Alumis (ALMS)
Bridgebio Pharma (BBIO)
Vera Therapeutics Cl A (VERA)
Insmed Com Par $.01 (INSM)
Anthem (ELV)
Agios Pharmaceuticals (AGIO)
United Therapeutics Corporation (UTHR)

View all positions for Exome Asset Management

Top funds holding Crescent Biopharma

FMR
BVF
Fairmount Funds Management
VR Adviser
Fcpm Iii Services B.v.
Balyasny Asset Management
Vestal Point Capital
Opaleye Management
Tang Capital Management
Vanguard Capital Management
Logos Global Management
Deep Track Capital
Rtw Investments
Millennium Management
Point72 Asset Management

View all funds holding Crescent Biopharma